tiprankstipranks
Tetra Bio-Pharma Inc (TSE:TBP)
TSX:TBP
Canadian Market

Tetra Bio-Pharma (TBP) Income Statement

Compare
83 Followers

Tetra Bio-Pharma Income Statement

Last quarter (Q3 2022), Tetra Bio-Pharma's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q3, Tetra Bio-Pharma's net income was C$-3.59M. See Tetra Bio-Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 21Dec 20Dec 19
Total Revenue
C$ 0.00C$ 0.00C$ 0.00
Gross Profit
C$ 0.00C$ 0.00C$ 0.00
Operating Expenses
C$ 24.30MC$ 20.46MC$ 13.86M
Depreciation and Amortization
C$ 111.95KC$ 34.38KC$ 27.48K
EBITDA
C$ -24.73MC$ -19.91MC$ -13.36M
Operating Income
C$ -24.84MC$ -19.94MC$ -13.39M
Other Income/Expenses
C$ -27.33MC$ -1.21MC$ -860.16K
Pretax Income
C$ -52.18MC$ -21.15MC$ -14.25M
Net Income
C$ -53.42MC$ -26.90MC$ -15.67M
Per Share Metrics
C$ ―C$ ―C$ ―
Basic EPS
C$ -0.12C$ -0.10C$ -0.08
Diluted EPS
C$ -0.12C$ -0.10C$ -0.08
Weighted Average Shares Outstanding
445.70M 258.15M 188.24M
Weighted Average Shares Outstanding (Diluted)
445.70M 258.15M 188.24M
Currency in CAD

Tetra Bio-Pharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis